Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Annals of Oncology Année : 2022

Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review

C. Corti
G. Antonarelli
J. Barrière
G. Curigliano

Résumé

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre-including this research content-immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
Fichier principal
Vignette du fichier
Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic review.pdf (1.12 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03955867 , version 1 (25-01-2023)

Identifiants

Citer

C. Corti, G. Antonarelli, F. Scotté, J.P. Spano, J. Barrière, et al.. Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review. Annals of Oncology, 2022, 33 (2), pp.158-168. ⟨10.1016/j.annonc.2021.10.014⟩. ⟨hal-03955867⟩
11 Consultations
50 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More